Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China

This study is not yet open for participant recruitment.
Verified June 2013 by West China Second University Hospital
Sponsor:
Collaborators:
Sichuan Academy of Medical Sciences
people's hospital of Guang'an
The first people's hospital of Neijiang
Suining Central Hospital
Sichuan Provincial Maternal and Child Health Care Hospital
Chengdu Women's and Children's Central Hospital
THE AFFILIATED HOSPITAL OF LUZHOU MEDICAL COLLEGE
pengzhou shi fuyou baojianyuan
NANCHONG CENTRAL HOSPITAL
Information provided by (Responsible Party):
Xinghui Liu, West China Second University Hospital
ClinicalTrials.gov Identifier:
NCT01804751
First received: March 1, 2013
Last updated: April 6, 2014
Last verified: June 2013
  Purpose

The purpose of this study is to build a model for the prediction of adverse perinatal outcome for preeclampsia in china


Condition
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by West China Second University Hospital:

Primary Outcome Measures:
  • maternal mortality [ Time Frame: within 48h of eligibility ]

Secondary Outcome Measures:
  • serious central nervous system morbidity [ Time Frame: within 48h of eligibility ]
  • serious cardiorespiratory morbidity [ Time Frame: within 48h of eligibility ]
  • serious hepatic morbidity. [ Time Frame: within 48h of eligibility ]
  • serious renal morbidity [ Time Frame: within 48h of eligibility ]
  • serious haematological morbidity [ Time Frame: within 48h of eligibility ]

Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Chinese women who fulfilled a research definition of preeclampsia, and who were admitted to participating obstetric centres

Criteria

Inclusion Criteria:

  • admitted with preeclampsia or had developed preeclampsia after admission

Exclusion Criteria:

  • admitted in spontaneous labour or had achieved any component of the maternal outcome before either fulfilling eligibility criteria or collection of predictor data
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Xinghui Liu, professor, West China Second University Hospital
ClinicalTrials.gov Identifier: NCT01804751     History of Changes
Other Study ID Numbers: hx2ck2
Study First Received: March 1, 2013
Last Updated: April 6, 2014
Health Authority: China:science & technology department of sichuan province

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications

ClinicalTrials.gov processed this record on April 17, 2014